Comparative Study on Postoperative Analgesia With Transversus Abdominis Plane Block to Local Anesthetic Infiltration With Ropivacaine in Laparoscopic Abdominal Surgery
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this clinical trial is to compare the postoperative analgesic efficacy of ultrasound-guided TAP block with Local Anesthetic Infiltration of ropivacaine in patients undergoing laparoscopic surgery. The main question it aims to answer is: • If Transversus Abdominis Plane block with Ropivacaine will produce long duration of analgesia than the Local Anesthetic Infiltration with ropivacaine after laparoscopic abdominal surgery .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2023
CompletedFirst Submitted
Initial submission to the registry
August 9, 2023
CompletedFirst Posted
Study publicly available on registry
August 16, 2023
CompletedAugust 28, 2023
August 1, 2023
8 months
August 9, 2023
August 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of analgesia
Visual analog scale at rest
Time Frame: upto first 24 hour after intervention
Secondary Outcomes (1)
Duration of analgesia
Time Frame: upto first 24 hour after intervention
Other Outcomes (3)
Time to first rescue analgesia
Time Frame: upto first 24 hour after intervention
Total pethidine consumption
Time Frame: upto first 24 hour after intervention
Total ketorolac consumption
Time Frame: upto first 24 hour after intervention
Study Arms (2)
Group I
EXPERIMENTALTransversus Abdominis Plane block
Group II
EXPERIMENTALLocal infiltration
Interventions
This group received 20ml of Ropivacaine 0.2% Injectable Solution in bilateral transversus abdominis plane at the end of surgery
This group received local infiltration of 20ml of Ropivacaine 0.2% Injectable Solutionat port sites at the end of surgery
Eligibility Criteria
You may qualify if:
- Adult patients of either sex aged 25-70 years
- ASA physical status I or II
- Patient posted for elective abdominal laparoscopic surgery.
You may not qualify if:
- Any absolute contraindications to peripheral nerve blockade
- History of Hypersensitivity to Drugs
- Uncontrolled Diabetes Mellitus, Renal Failure, Hepatic failure
- History of neuromuscular or psychiatric disease
- Patient receiving psychotropic drug, chronic analgesic therapy
- Pregnancy
- Patient weight less than 50 kg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Academy of Medical Sciences
Kathmandu, Bagmati, 977, Nepal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Surendra Bhusal, MD
NAMS Bir Hospital
- STUDY DIRECTOR
Brihaspati K C, MD
NAMS Bir Hospital
- STUDY CHAIR
Kaushal Tamang, MD
NAMS Bir Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Patients were randomly assigned to two groups having 50patients in each, by using a computer-generated table of random numbers which was enclosed in a sealed envelope and was opened by an anesthesia assistant who was not involved in the study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 9, 2023
First Posted
August 16, 2023
Study Start
March 12, 2022
Primary Completion
November 12, 2022
Study Completion
February 25, 2023
Last Updated
August 28, 2023
Record last verified: 2023-08